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1. Introduction
Visceral leishmaniasis (VL) is a serious public health problem of great medical and veterinary
importance. This disease is endemic in Brazil and in many other countries of Latin America,
Asia, Africa and Europe (1). According to recent review (2), approximately 0.2 to 0.4 million
cases of VL occur each year and although worldwide distributed, higher prevalence of the
disease is concentrated in six countries, including India, Bangladesh, Sudan, South Sudan,
Ethiopia and Brazil, that undertake for more than 90% of the cases. The clinical importance of
VL resides in the severity of the disease that results in death of unrecognized cases and even
for individuals with treatment access, death occurs in 10 to 20% of the cases [2-8].
Most of the VL cases are caused by the Leishmania species from Leishmania donovani com‐
plex. Parasites from the Leishmania genus are diphasic and are transmitted as promastigote
form to vertebrate hosts through the bites of female sand flies [9-12]. The genetic similari‐
ties between Old World and New World strains, respectively, of L. infantum and L. infan‐
tum (syn. chagasi) from different regions in Latin America, indicate these parasites belong to
the same origin [11, 12].
The notion that dogs are the main urban domestic reservoir for this Leishmania in certain part
of the globe is supported by the facts including: i) cases of canine visceral leishmaniasis (CVL)
have been reported in 50 of the 88 countries where VL is endemic [13], ii) canine cases precede
the onset of human cases [14], iii) high rates of prevalence in dogs, and iv) frequency of parasites
is high in dog skin [15-18].
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Control strategies include performing accurate and early diagnosis of CVL to identify infected
animals [19, 20]. CVL diagnosis is a difficult task since clinical signs of the disease in dogs can
be confused with other diseases [19]. In endemic areas, a large percentage of infected animals
are asymptomatic or present low number of discrete signs. The role these animals play in
parasite transmission is still largely unknown. Several diagnostic strategies have been
implemented based on parasitological, serological or molecular methods in association with
clinical and epidemiological parameters [21]. Parasite culturing has been considered as gold
standard for disease diagnosis [22, 23]. Although offering a high specificity since allows
parasite identification, it offers very low sensitivity, besides it is laborious, time-consuming
and largely dependent on the expertise of the observer [24, 25].
Serological tests are the most common diagnostic method employed for CVL diagnosis [3].
Several serological methods have been implemented for diagnosis of CVL, including direct
agglutination assay (DAT), enzyme linked immunoassay (ELISA) and indirect immunofluor‐
escent antibody test (IFI) [26]. However, most of these classical serological tests present
important limitations for CVL diagnosis, including high consumption of time, and lack of
sensitivity and specificity, mainly when animals present low antibody titers. This causes
underestimation of disease, reflecting in failures in control measures, as well as the mainte‐
nance of infected untreated dogs in endemic areas [27, 28]. New methods based on immuno‐
chromatography have been implemented for serodiagnosis of CVL and have shown excellent
results [29]. These techniques offer several advantages since they are rapid tests easily
performed even in field areas, and more specific since they use recombinant DNA technology
that additionally facilitates reproducibility and large-scale production. These advantages
result in better identification of infected dogs. However, the efficacy of immunochromato‐
graphic techniques for CVL diagnosis needs to be improved [30]. In Brazil, a rapid test based
in dual path platform (TR DPP®LVC - Biomanguinhos) had been recently implemented as
screening test for CVL. This technique seems to be adequate to disease diagnosis in public
health system. However, the TR DPP®LVC has shown an excellent performance identifying
98% of symptomatic dogs, it showed less efficacy for diagnosis of asymptomatic dogs (47%)
[31]. Since there is evidence that asymptomatic dogs can participate in natural transmission
cycle of VL, new strategies should be implemented in order to improve CVL diagnosis [16,
32-34]. For serological diagnosis one strategy can be the development of rapid tests based on
impregnation of multi-antigen that would offer more sensitivity, as well specificity.
Finally, it would be important to include more specific confirmatory tests for control strategies
that can be advantageous to diagnose inconclusive cases. There is evidence that molecular
diagnosis of Leishmania spp. provides high levels of sensitivity and specificity when compared
to other diagnostic methods [7, 17]. The use of quantitative methods in molecular level allows
not only a more accurate detection but also monitoring tissue parasite load in dogs following
anti-leishmanial treatment [35-37].
2. Importance of CVL diagnosis
Since the discovery of canine visceral leishmaniasis (CVL) in Tunisia by Nicolle & Comte
(1908), several reports have shown that dog and man share a common etiologic agent. The
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notion that dog is the main reservoir of visceral leishmaniasis (VL) in urban centers [38] is
supported by several evidences including the high cutaneous parasitism observed in dogs
infected by Leishmania [15-18], the high rates of prevalence observed among dogs in endemic
areas, and the observation that the appearance of canine cases precedes the emergence of
human cases [14]. Some studies conducted in endemic regions, where VL occurs in a zoonotic
cycle, point to a prevalence of approximately 20% of VL-positive dogs, as described in China
[39], Greece [40], and Mexico [41]. In other endemic areas, rates of Leishmania infection detected
in dogs range between 60 and 80% [4, 42-44]. However, in spite of the high prevalence of
Leishmania infection, not all dogs exhibit signs of clinical disease and sick dogs may display
clinical signs of variable intensity [4, 42, 45]. Differences in clinical manifestations among dogs
as the number of clinical signs and the time to onset of the disease may vary depending on the
individual immune response of the infected dog. Three forms of progression of infection by
L. infantum have been described: about 46% of infected dogs acquire the infection and develop
the disease immediately, another 44% of dogs develop the disease later and 10% of them never
develop CVL [46-48]. Similar to that which occurs in humans, characteristics such as genetic
factors, age and nutritional status may influence the progression of VL in dogs [13, 49, 50].
Some studies have shown a correlation between the presence of clinical signs in infected
animals and transmissibility of the parasite to the vector and, consequently, a correlation with
the occurrence of human cases [16, 32, 51]. In accordance with these studies, Travi et al. (2001)
and Verçosa et al. (2008) showed that asymptomatic dogs did not transmit the parasite to the
vector [38, 51]. There is not a consensus about this idea, since there is a wide variation in the
rates of infectivity (70 to 90%) between asymptomatic and symptomatic dogs. Studies show
that, regardless of the clinical presentation, any dog has the ability to transmit Leishmania to
the vector, even though the symptomatic animals are more likely to disseminate the disease
[16, 32, 52, 53], being more capable of transmitting the parasite to the vector and, consequently,
to another dog or a human [33, 34, 54, 55]. Based on studies showing that the dog can transmit
the disease regardless of its clinical form, in some countries such as Brazil, dog culling is
recommended as a control strategy. This control measure is not well accepted, having its
effectiveness questioned and demanding studies to increase the diagnostic methods perform‐
ance. Additionally, identification of new antigens will allow not only improvement of
diagnosis, but also differentiation of dogs that transmit, from those that do not transmit the
parasite in an endemic area.
3. Visceral leishmaniasis diagnosis in dogs
The diagnosis of VL in the dog must consider the association between clinical, laboratory and
epidemiological data. As discussed above, clinical diagnosis is problematic and difficult for
veterinarians to perform due to the great variability of clinical signs that Leishmania-infected
dogs may present, as long as to its similarity with clinical profiles of other diseases. In clinical
practice, identification of characteristic manifestations should be confirmed by ascertaining
the infection using laboratory techniques [56] that vary in accuracy [57, 58].
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There are several laboratorial diagnosis methods for leishmaniasis: i) parasitological methods
(detection of the parasite), ii) serological methods (detection of anti-Leishmania antibodies), iii)
molecular methods (amplification of parasite DNA) and iv) assay of cell-mediated immunity.
This last method not being widely applied to routine diagnosis and will not be discussed in
the present report. It should be noted that, although there is a wide variety of diagnostic
techniques for CVL, none of them offer 100% of sensitivity or specificity [35, 59].
In spite of serological techniques such as enzyme-linked immunosorbent assay (ELISA) and
indirect immunofluorescence assay (IFAT) being the most widely used methods for the
diagnosis of CVL [60] parasitological methods, such as direct examination of slides and
isolation from tissue cultures, allow the parasite to be detected and can be used as confirmatory
diagnostic methods for CVL [61]. In recent decades, molecular techniques such as polymerase
chain reaction (PCR) have been introduced for the diagnosis of CVL, exhibiting high sensitivity
and specificity [21]. These techniques detect the genetic material of the parasite, which can be
used as confirmatory methods in cases of recently infected or asymptomatic animals, which
tend not to be diagnosed serologically, and in most cases, do not show seroconversion, having
a low parasite load [4, 60]. In a study conducted in Belo Horizonte-MG, a VL-endemic area in
Brazil, among 1,443 dogs evaluated, 15.3% of them were seropositive, while 84.7% showed
negative serology. Interestingly, among serologically negative dogs, 24.4% showed up as
positive using the molecular diagnostic technique, and most of these (97.6%) would not be
diagnosed, since they consist of asymptomatic dogs with negative serology [19].
3.1. Clinical diagnosis
Dogs from endemic areas considered resistant remain clinically normal and asymptomatic
without exhibiting clinical signs. There is evidence that the parasites in these animals are
effectively eliminated at the infection site [62, 63]. However, in susceptible animals, a large
number of parasites are detected in infected tissues. In these animals, the presence of the
parasite may occur in multiple organs, accompanied by a granulomatous inflammatory
reaction and production of immune-mediated phenomena, probably responsible for the
appearance of various types of clinical signs [64].
Initial clinical signs of CVL include: hypertrophy of the lymph nodes, changes in skin appen‐
dages such as onychogryphosis, swelling of the footpad, localized alopecia, skin ulcers and
nasal and periocular dermatitis. Alopecia and non-pruritic exfoliative dermatitis can spread
to other parts of the animal's body. Weight loss may also be present, as well as cachexia,
anorexia and conjunctivitis. Internal organs such as spleen, liver, kidney and lymph nodes
may also be affected, when kidney injuries are present may lead to the dogs death [13, 65].
Fever, apathy, diarrhea, epistaxis, intestinal bleeding, hepatosplenomegaly, hyperkeratosis,
keratoconjunctivitis are also found in affected animals [66-68]. Some clinical signs are more
frequent than others; skin lesions are the most frequent manifestations affecting approximately
50 to 90% of symptomatic dogs [4, 67, 69, 70], including non-pruritic exfoliative dermatitis,
with or without alopecia, which can be generalized or localized to the muzzle, ears and limbs
[67, 71, 72]. Other very common signs are weight loss, observed in 25 to 80% of CVL cases,
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including onychogryphosis in 30 to 75%, and ocular abnormalities in 16 to 24% [28]. The most
common clinical signs of VL in dogs are depicted in Figure 1.
A B C 
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Figure 1. Major clinical signs associated with CVL. A: alopecia on the muzzle, B: periocular dermatitis with keratocon‐
junctivitis and hyperkeratosis; C: hyperkeratosis of the nasal mucosa; D: generalized non-pruritic exfoliative dermatitis;
E: ulcerated lesion in the ear; F: crust with vascular injury on the tip of the ear; G: lymphadenomegaly of the popliteal
lymph node; H: cachexia; I: onychogryphosis. Photos of animals infected by L. infantum belong to archives from Labo‐
ratory of Pathology and Biointervention(LPBI - CPqGM).
In dogs with CVL, clinical-pathological changes may occur such as intestinal lesions, renal and
hepatic abnormalities [73]. The main biochemical laboratory findings from CVL are hyper‐
globulinemia, mainly due to increased production of antibodies, and hypoalbuminemia,
attributed to chronic inflammation, as long as renal and hepatic failure [66]. The result of these
changes is a reduction in the albumin/globulin ratio and hyperproteinemia [28]. Additionally,
severe CVL is associated with changes in hematological parameters such as severe anemia and
leukopenia, associated with lymphopenia, eosinopenia and monocytopenia [66, 74, 75].
New Advances in the Diagnosis of Canine Visceral Leishmaniasis
http://dx.doi.org/10.5772/57573
243
Immune-mediated thrombocytopenia also occurs accounting for episodes of bleeding such as
epistaxis, hematuria and hemorrhagic diarrhea [76].
Finally, nonspecific signs of illness that are mistaken for other diseases such as babesiosis,
ehrlichiosis and canine trypanosomiasis also contribute to make CVL clinical diagnosis
imprecise and difficult to perform [13].
3.2. Parasitological diagnosis
The detection by optical microscopy of the parasite by direct observation of stained smears
from spleen aspirate, lymph node and bone marrow tissues has high specificity, allowing
confirmation of CVL diagnosis [3, 53, 61, 77]. However, the sensitivity of this method is less
than 30%, since the direct parasite identification may be limited, especially in mildly and
asymptomatic dogs that have low parasitic load, producing false negative results [3, 53, 61, 77].
Another method that can identify the parasite in tissues is the culturing of tissue fragments or
aspirates, preferably in a biphasic medium [78], composed by Novy-MacNeal-Nicolle (NNN),
or Tobie modified medium or United States Army Medical Research Units (USAMRU) as solid
phase medium and, most often, Schneider as liquid phase medium. This parasitological
diagnostic method offers high specificity allowing isolation and characterization of parasites,
as well as determination of which species and/or variants are circulating in endemic areas [79].
However, the culturing consists of an indirect test, because when the parasites are isolated
from various tissues, they are present in amastigote form and during cultivation they transform
into the promastigote form. This process may be impaired as a result of parasite death due to
a failure of temperature-control during transport of the tissue sample, or contamination during
collection or cultivation [13]. Additionally, a culturing is time consuming and may take up to
4 weeks of observation for definitive diagnosis [13, 79]. Furthermore, specific media for
promastigote isolation are not easily obtained, being a technique restricted to specialized
laboratories [70, 80], in which the outcome also depends on the experience of the observer [24,
25]. Although culturing offers greater sensitivity compared to direct viewing of amastigotes
in tissue [35], it still remains at very low levels.
In summary, parasitological techniques have high specificity but low sensitivity, especially for
the detection of dogs, recently infected, asymptomatic or those presenting low parasite load.
In addition, the need for skilled personnel and the long delays to obtain the results prevent
parasitological techniques to be used in epidemiological surveys [4, 23, 61, 81-84].
3.3. Serological diagnosis
Serological tests are based on the presence of specific humoral immune responses against the
pathogen or purified fraction or recombinant proteins of the pathogen. These tests allow
detection of immunoglobulin (IgG) levels, thus becoming an essential tool for the diagnosis of
CVL. These methods are simple to carry out and therefore they are frequently used to
determine the prevalence of leishmaniasis in epidemiological studies [85].
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A wide variety of serological methods are available for CVL diagnosis, presenting variations
in sensitivity and specificity. The performance of these diagnostic techniques varies depending
on the type of antigen used and the detection of anti-Leishmania antibody system.
The most commonly employed serological tests for the diagnosis of CVL, including ELISA,
indirect immunofluorescence test (IFAT), and direct agglutination test (DAT), uses parasite or
crude extract of Leishmania, as the antigen source. More recently, serological methods based
on ELISA or rapid tests have been developed using a purified fraction of the parasite or a
specific purified recombinant protein, such as rK39 or a chimeric protein as rK28 (rK9 + rK26
+ rK39).
Despite the practicality and simplicity of serological tests, they do not have 100% sensitivity
because some dogs, especially those that are resistant or in the early stages of the disease, have
negative results. Thus, the results of such tests should be evaluated carefully, always associ‐
ating test results with epidemiological history, clinical state of the animal, and the result of a
more specific diagnostic test [86]. In addition, since titers of anti-Leishmania antibodies remain
detectable for long periods, serological tests are not a good alternative for assessing healing or
monitoring dogs after treatment [71].
• IFAT
IFAT is a test in which anti-immunoglobulin antibodies labeled with fluorochromes react with
parasites immobilized in a slide. IFAT is a laborious technique that presents difficulties for
both standardization and interpretation of the results Therefore, detection of antigen-antibody
reaction by fluorescence microscopy depends on the observer experience, compromising
reproducibility of this test in different laboratories. Thus, it is not considered a simple and
practical technique for evaluating a large number of canine sera [57]. In spite of these limita‐
tions, it is still being used as a diagnostic method for mass screening of infected dogs [87]. This
method varies in its performance, with sensitivity ranging from 68 to 100% and specificity of
60 to 90% [5, 88-90].
In a study evaluating IFAT for the diagnosis of CVL, the efficacy of the test was evaluated
using 254 sera from infected and uninfected dogs and sera from animals with other parasitic
diseases. The authors observed low sensitivity (72%) and specificity (52%), as well as cross-
reactions when sera from dogs infected with other pathologies, such as Trypanosoma cruzi,
Leishmania braziliensis, and Ehrlichia canis were tested. In this study, the reproducibility of the
results among different laboratories yielded a moderate rate of 0.74 [5]. A similar result was
obtained by Lira et al. (2006) that using IFAT, found a low sensitivity and specificity of 68%
and 87.5%, respectively [88]. By contrast, it was shown by Alves and colleagues that the IFI-
CVL kit, IFAT produced by Biomanguinhos (Brazil), provides high sensitivity (100%),
detecting all dogs with CVL, although presenting a low specificity of 70%, levels similar to
those observed in studies described above. This low level of specificity was due to false positive
results from sera of dogs infected with Trypanosoma caninum (48.7%) and healthy dogs (10.3%)
[90]. Thus, the Brazilian Ministry of Health withdrew the IFI-CVL kit from the CVL control
program, due to data in literature that support IFAT has both low sensitivity, which led to
New Advances in the Diagnosis of Canine Visceral Leishmaniasis
http://dx.doi.org/10.5772/57573
245
maintenance of false-negative dogs in the endemic areas, and low specificity, which promoted
the culling of false-positive dogs [65, 91, 92].
• DAT
The direct agglutination test (DAT) is an alternative method for the diagnosis of VL, first
described in 1975 and adapted for the diagnosis of human and canine infection in the late 1980s
[93, 94]. DAT is a method that uses whole stained promastigotes as antigen, either in suspen‐
sion or freeze-dried [35]. The advantage of this test lies in its low cost when compared with
other tests [93]. However, this test is not desirable for screening large numbers of samples,
since it is a laborious procedure, due to the production process for crude Leishmania antigen,
as well as the need to perform serial dilutions of serum [95, 96]. Regarding the accuracy of
DAT, there is some controversy in the literature, the sensitivity appears relatively variable
between 88 and 93% and specificity of 70 to 100% [5, 59, 96, 97]. It is likely that these variations
are related to how the cutoff is defined, since cutoffs using smaller dilutions reduce sensitivity
but raise the specificity, while those using higher dilutions increase sensitivity and reduce
specificity [98].
Changes to the DAT protocol have been proposed by Gómez-Ochoa et al. (2003) in order to
decrease the cost of the procedure and the preparation time of the antigen, while maintaining
the same sensitivity and specificity of conventional DAT. One of the proposed changes for
DAT protocol is the fast agglutination-screening test (FAST), which combines a higher
concentration of parasites with a smaller test volume. FAST requires a single serum dilution
and the results can be read in 3 hours [95, 96]. However, in spite of the sensitivity of this
technique being greater than that of conventional DAT, which varies from 93 to 98%, the
specificity values were similar to those from the conventional DAT, between 78-89% [95, 96].
• ELISA
For various reasons, ELISA tests based on whole parasites or crude lysate of parasite antigens
for the diagnosis of CVL do not provide satisfactory results, as follows: i) it is a laborious
technique, which leads to a delay in the delivery of results and, consequently, the implemen‐
tation of treatment or the removal of infected dogs from endemic areas [68, 99]; ii) leads to the
appearance of cross-reactions with sera from individuals infected with other Leishmania species
or even with a variety of other pathogens such as Toxoplasma gondii, Ehrlichia canis [23, 24, 29,
100-103],and parasites of the Trypanosomatidae family such as Trypanosoma cruzi [5, 29] or
Trypanosoma caninum [90] iii) there are reports of low reproducibility between batches of ELISA
based on whole parasites or crude antigens, since different isolates of Leishmania sp. were used
and depending on the culturing batch, distinct antigenic compositions can be detected [104].
A study using 234 domesticated dogs in an endemic area for CVL assessed the efficacy of
ELISA, IFAT and DAT for the diagnosis of CVL. In this study, dogs were also parasitologically
evaluated for identification of Leishmania amastigotes in both skin samples and bone marrow
aspirates. The sensitivity of IFAT was 72% and ELISA was 95%. When the tests were evaluated
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against sera from dogs infected with other pathogens, T. cruzi, E. canis and L. braziliensis, the
specificity of these tests shown to be very low 52% for IFAT and 64% for ELISA [5].
Using sera from dogs with CVL, a comparison of an ELISA test using crude soluble antigen of
L. infantum (SLA) and another ELISA test based on ribosomal protein of L. infantum (LRP) was
made. The sensitivity of the two tests was similar when evaluated against sera from sympto‐
matic animals (100%), but the ELISA based on LRP showed also higher sensitivity, reaching
100% in the detection of asymptomatic dogs, when compared with ELISA using SLA (19%).
Additionally, the LRP-based ELISA showed high specificity (98%), with no cross-reactivity
with sera from dogs with other diseases [102].
Thus, the search for tests with higher sensitivity and specificity for dogs with a variety of
conditions became necessary for control of CVL, which would lead to a reduction of errors in
actions taken for treatment or control. In countries that adopt culling of seropositive dogs as
a control measure, low sensitivity of diagnostic tests can lead to the maintenance of dogs that
transmit disease and lack of specificity can result in unnecessary culling of healthy dogs. The
identification of new proteins of Leishmania sp. in order to compose diagnostic tests for CVL
can improve both sensitivity and specificity of diagnostic techniques and allow infected dogs
to be differentiated from the uninfected ones [5, 29, 87, 105, 106].
Another way to overcome the obstacles of ELISA based on whole parasites or crude parasite
antigen was the development of ELISA tests based on parasite fractions such as that using the
parasite surface molecule, fucose-mannose ligand antigen (FML). The FML-based ELISA
showed a high sensitivity, which was similar in detecting either oligosymptomatic (90%) or
symptomatic (90%) dogs. Regarding specificity, ELISA using crude parasite antigen for the
diagnosis of oligosymptomatic dogs was superior, achieving 100% in comparison to FML-
based ELISA that was 93.3%. However, for symptomatic dogs the specificity of the FML-based
ELISA showed similar results of 96.7% compared to that obtained by ELISA based on crude
parasite antigen (93.3%) [101].
Other ELISA assays based on recombinant antigens such as rA2 from L. donovani, rK26 or rK39
from L. infantum have been developed. When compared to an ELISA test based on crude
antigen, taking IFAT as the gold standard, and tested against sera from symptomatic dogs,
sensitivities was higher for ELISA based on rK26 or rK39 from L. infantum, respectively, of 94%
and 100% in comparison to 88% for ELISA based on crude antigen and 70% for ELISA based
on rA2 from L. donovani. However, ELISA based on rA2 showed the highest specificity value
of 96% in comparison to those from ELISA based on crude parasite antigen or parasite
recombinant antigens rK26, rK39, that showed values of, respectively, 87%, 90%, and 85% [29].
Although good enough for diagnosis of symptomatic dogs, the use of ELISA tests based on
recombinant antigens for the diagnosis of asymptomatic dogs seems to be disadvantageous.
ELISA based on rA2 gave the lowest sensitivity of 30%, followed by rK26 and rK39 that
sensitivity yielded greater, but still stayed low with value of 66% for both tests, in comparison
to the sensitivity of 88% for ELISA based on crude parasite antigen. By contrast, another in a
multicenter study conducted in 5 regions of Italy using IFAT as gold standard, ELISA based
on the recombinant antigen rK39 gave higher levels of sensitivity and specificity of 97.1% and
New Advances in the Diagnosis of Canine Visceral Leishmaniasis
http://dx.doi.org/10.5772/57573
247
98.8%, respectively [107]. It is possible that the differences found in relation to the performance
of the ELISA containing these proteins may be related to the study design, characterization of
serum samples and the experimental protocols of the ELISA assays.
Interestingly, the association of the recombinant proteins enhanced test performance both for
detection of symptomatic and asymptomatic infected dogs. Indeed, using IFAT as the gold
standard, ELISA based on the mix of rK9, rK26 and rK39 from L. donovani showed sensitivity
of 95-100% and specificity of 100% against a panel of serum from parasitologically positive
dogs, using parasitologically and serologically negative dogs as controls [108]. Furthermore,
ELISA containing a chimeric protein rK28, containing reactive epitopes of the three recombi‐
nant proteins described above (rK9, rK26 and rK29), shown to present high levels of sensitivity
and specificity of 99% and 96%, respectively when tested against a panel of serum from dogs
parasitologically positive or serologically positive using IFA, and sera from parasitologically
negative dogs as controls [87]. In this study, the authors didn’t evaluate rK28-based ELISA
against sera from asymptomatic dogs.
The combination of these findings reinforces the notion that the use of multiple antigens in
diagnostic tests enhances test performance and the need to search for new antigens that may
compose a diagnostic test able to better diagnose asymptomatic dogs.
New recombinant proteins are being evaluated. Faria et al. (2011) performed predictions on B-
cell epitopes, identifying 360 peptides that were synthesized onto nitrocellulose membranes
[105]. The 10 most reactive were evaluated in an ELISA platform. The sensitivity and specificity
of the ELISA based on these peptides varied from 70.96% to 88.7% and 55% to 95.0%, respec‐
tively, a better result than that obtained with EIE-CVL kit, which gave a sensitivity of 13.8%
and specificity of 100%.
Another study evaluated the performance of the ELISA based on another recombinant antigens
of L. infantum, rLci1A and rLci2B, against a panel of canine sera (n = 256). ELISA based on
rLci1A gave sensitivity of 96% and specificity of 92% for rLci1A and sensitivity of 100% and
specificity of 95% for rLci2B. The recombinant antigens showed no cross-reactivity with sera
from dogs infected with Trypanosoma caninum, Babesia canis and Ehrlichia canis. Cross-reaction
against sera from dogs infected with Leishmania braziliensis was observed for rLci1A-based
ELISA (11.7%) and for rLci2B-based ELISA (2.9%) [109].
In summary, most studies using ELISA suggest that in comparison to tests based on crude
antigen, those based on recombinant antigens improves accuracy, increasing sensitivity and
specificity for the diagnosis of symptomatic dogs. Although improved, test accuracy is still
low for the detection of asymptomatic animals.
• Rapid tests
Recently, rapid immunodiagnostic tests have begun to be employed as routine laboratory
tests for detection of diseases such as leishmaniasis. The recombinant antigens of the parasite
are impregnated onto nitrocellulose membranes and serum samples are applied in the rapid
test platform. Antigens impregnated in nitrocellulose membranes are recognized by specific
immunoglobulin present in the serum of infected individuals. This reaction is revealed by
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the interaction of protein A coupled to colloidal gold particles, with the Fc portion of the
immunoglobulins associated with the recombinant antigens. The use of immunochromato‐
graphic assays as diagnostic methods has the main advantages of being rapid, completed
in around 15 minutes, easy to carry out and can dispense with the need for equipment to
read  the  results  [110].  Furthermore,  these  tests  are  easily  stored,  and  test  supplies  and
samples do not need to be maintained at low temperatures and can it even be performed
at the place of collection. These tests are already widely used to detect HIV [111] and H1N1
[112] infection. For the diagnosis of CVL and human VL, among the tested and commercial‐
ly available recombinant proteins, the most widely used for composing immunochromato‐
graphic tests is the recombinant protein rK39. This protein contains repetitive sequences of
39 amino acids from a protein related to kinesin of kinetoplast from L. infantum, and has
been widely used in ELISA platform as described above [30, 31, 91, 96, 97, 110, 113-119].The
efficacy of rK39-based rapid lateral flow test was compared with the IFAT against sera of
parasitologically positive dogs from Italy. Both tests offered similar sensitivities of 97% for
the lateral flow test in the dipstick format and 99% for the DAT, as well as the maximum
specificity of 100% in both tests [120]. Similar results were obtained in other study which
detected sensitivity of 97% and specificity of 100% using the rK39 dipstick for diagnosis of
CVL, indicating that the rK39 dipstick is promising for both large-scale screening in endemic
areas and for veterinary clinical practice [121]. However, other studies also conducted in
endemic areas for CVL showed that the dipstick based on the recombinant protein rK39
offered inferior performance to that of the studies described above, with sensitivity values
of  61-75%  and  specificity  of  72-84.9%  [122,  123].  These  differences  in  performance  be‐
tween these studies using dipsticks tests based on rK39 may be related to the use of sera
from dogs with different conditions and therefore with varying concentrations of specific
immunoglobulins [29-31, 118, 122]. Effectively, another study employing the rapid test based
on  the  recombinant  protein  rK39  dipstick  offered  a  sensitivity  of  96.7%  for  sera  from
symptomatic dogs, compared to a sensitivity of 52.9% when evaluating sera from asympto‐
matic dogs [119]. Similarly, another study found that using sera from asymptomatic dogs
that the sensitivity of the dipstick based on rK39 was 75% compared to sensitivities of 88%
and 84% for sera from oligosymptomatic and polisymptomatic dogs, respectively [118]. In
the same study, an ELISA based on crude parasite antigens yielded a sensitivity of 94%
tested  using  sera  from  asymptomatic  and  oligosymptomatic  and  95%  using  sera  of
polisymptomatic dogs.
Recently, a meta-analysis was performed in order to broadly assess the performance of rapid
tests using rK39 as the antigen in the diagnosis of CVL. The combined analysis of 16 studies
using rapid tests based on rK39 offered a sensitivity of 86.7% (95% CI: 76.9–92.8%) for the
detection of clinical disease and 59.3% (95% CI: 37.9–77.6%) for identification of Leishmania
infection with a specificity of 98.7% (95% CI: 89.5–99.9%). In summary, this study supports the
idea that the rapid test based on rK39 is useful to confirm the disease in dogs with clinical
suspicion. However, given its low sensitivity for the diagnosis of asymptomatic dogs, its use
is not recommended for large-scale epidemiological studies or VL control programs [30].
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Harith et al., 1989 DAT L. infantum
promastigotes
44 6 176 98.9 100
Barbosa-de-Deus et al.,
2002
ELISA LMS 188 1582 55 98.0 95.0
Scalone et al., 2002 ELISA K39 209 81 62 97.1 98.8
Schallig et al., 2002 DAT L. donovani
promastigotes
79 67 24 88.6 96.7
FAST L. donovani
promastigotes
79 67 24 93.6 89.0
Rosati et al., 2003 ELISA K26 202 20 0 100 100
ELISA K9 202 20 0 95 95
ELISA K39 202 20 0 95 95
Mohebali, et al., 2004 Dipstick rK39 268* 0 0 70.9 84.9
Boarino et al., 2005 ELISA K9-K39-K26
chimera
232 362 0 95.8 99.1
Mettler et al., 2005 Rapid test rK39 47 50 26 A: 52.9
S: 96.7
94
IFAT L. infantum
promastigotes
47 50 26 A: 29.4
S: 90.0
100
Lira et al., 2006 EIE® - LVC L. major lysate 25 16 11 72.0 87.5
IFI® - LVC L. major like
promastigotes
25 16 11 68.0 87.5
Ferreira et al., 2007 EIE® - LVC L. major lysate 234* 20 20 96.0 100
IFI® - LVC L. major like
promastigotes
234* 20 20 72.0 100
DAT L. donovani
promastigotes
234* 20 20 93.0 100
Ferroglio et al., 2007 SNAP® CLATK CTA 59 124 0 91.1 99.0
Porrozzi et al., 2007 ELISA rK26 100 25 14 A: 66.0
S: 94.0
90.0
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ELISA rK39 100 25 14 A: 66.0
S: 100
85.0
ELISA rA2 100 25 14 A: 88.0
S: 70.0
96.0
ELISA CTA 100 25 14 A: 30.0
S: 88.0
87.0
Cândido et al., 2008 ELISA CTA 60 30 0 O: 86.7
P: 90.0
O: 100
P: 93.3
ELISA FML 60 30 0 O: 90.0
P: 86.7
O: 93.3
P: 96.7
Lemos et al., 2008 RDTs rK39 76 33 0 83 100
ELISA L. chagasi lysate 76 33 0 95 100
Babakhan et al., 2009 FAST L. infantum
promastigotes
73 74 0 98.6 78.7
Coelho et al., 2009 ELISA LRP 111 47 14 100 98.2
ELISA CTA 111 47 14 96.0 100
Troncarelli et al., 2009 IFAT L. major like
promastigotes
51 0 0 83.0 92.5
Figueiredo et al., 2010 EIE® - LVC L. major lysate 305* 0 0 100 96.6
IFI® - LVC L. major like
promastigotes
305* 0 0 22.2 97.0
de Lima et al., 2010 ELISA CTA 52 52 0 91.5 94.7
RDTs rK39 52 52 0 100 91.2
Marcondes et al., 2011 SNAP® CLATK CTA 283 86 31 94.7 90.6
Alves et al., 2012 EIE® - LVC L. major lysate 39 39 39 100 68.0
ELISA L. chagasi lysate 39 39 39 100 93.6
IFI® - LVC L. major like
promastigotes
39 39 39 100 70.5
IFAT L. chagasi lysate 39 39 39 100 61.5
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DPP® - LVC rK28 39 39 39 100 97.5
Grimaldi et al., 2012 DPP® - LVC rK28 120 59 11 A: 47.0
S: 98.0
96.0
Souza et al., 2012 ELISA rLci1A 138 119 86 96.0 92.0
ELISA rLci2B 138 119 86 100 95.0
Barral-Veloso et al., 2013 ELISA L. infantum
promastigotes
fixed with β-
mercaptoethanol
31 37 45 93.5 97.6
ELISA L. infantum
promastigotes
fixed with trypsin
31 37 45 87.1 100
Quinnell et al., 2013 RDTs rK39 322 59 0 46.0 98.7
* Dogs from an endemic area for CVL without confirmed diagnosis.
A: asymptomatic dogs; S: dogs with clinical signs related to CVL; O: oligosymptomatic dogs (presenting one to three
clinical signs of CVL); P: polysymptomatic dogs (presenting more than three clinical signs of CVL).
RDTs = Kalazar Detect - Canine Rapid Test
LMS = L. major like promastigotes lysate
CTA = Crude Total Antigen - antigenic fractions of L. infantum promastigotes form
FML = Fucose-Mannose Ligand antigen - glycoprotein complex isolated from the surface of L. donovani
LRP = Leishmania species ribosomal proteins
Table 1. Sensitivity and specificity of some serological techniques by type of antigen, and evaluated population
Efforts have been made to improve the efficacy of rapid tests by developing more sensitive
and specific method that could be used in mass screening for the diagnosis of CVL. An
alternative proposal is to use a mixture of recombinant proteins or chimeric proteins. The
protein rK28 chimeric for the relevant epitopes of three antigens, rK9, rK26 and rK39 [87, 108]
that showed promising efficient results in an ELISA based test [124], was recently used to
compose a new rapid test in DPP format. This format consists of a double track platform that
offers greater sensitivity and specificity [125]. In addition, this rapid test has advantages over
previously used serological methods due to greater precision, simplified interpretation of the
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data, minimal use of sample volumes, and compatibility with different types of body fluids
such as blood, serum, saliva, plasma and urine. In contrast to these advantages, recently
Grimaldi et al (2012) showed that rK28-based DPP despite its high sensitivity (98%) and
specificity (96%) towards sera from symptomatic dogs, showed low sensitivity of only 47%
towards sera from dogs with no signs [31]. With regard to sera from dogs with other diseases,
the observed specificity was 96%, with false-positive reactions mainly for some sera of dogs
infected with L. braziliensis. Thus, L. infantum may not be detected in serological investigations
of asymptomatic infected dogs, leading for perpetuation of the parasite cycle and, conse‐
quently, hampering the efficacy of the disease control measures. This limitation is reason for
concern because several studies indicate that asymptomatic dogs are involved in transmission
of infection to the vector, although this occurs less frequently than with symptomatic dogs [16,
32-34]. Therefore, it is necessary to implement more effective serodiagnostic tests so that there
is broader detection of animals infected with L. infantum by public health services, contributing
to more efficient control of CVL.
3.4. PCR
In recent decades, due to advances in molecular biology techniques and reduced implemen‐
tation costs, the polymerase chain reaction (PCR) began to be used in VL diagnosis [23, 126].
Its use has demonstrated superior results to those obtained by ELISA, IFA and culture in
detecting animals infected with Leishmania sp., exhibiting high sensitivity and specificity [23,
126].
PCR is a technique based on the principle of complementary bases pairing of the DNA
molecule, allowing amplification and detection of a particular region of the target genome
using a pair of specific oligonucleotide primers. The reaction can produce tens of billions of
DNA fragments from a single molecule, and has high sensitivity small quantities of samples
to be used. This type of PCR, hereafter referred as "conventional PCR" (cPCR) needs electro‐
phoresis in agarose or polyacrylamide gels along with dyes such as ethidium bromide, SYBR
Green or silver nitrate to view the amplified product. This approach is usually qualitative, with
analysis of the presence or absence of bands, or semi-quantitative, when densitometry of bands
is used in comparison with known standards. Since it uses qualitative or semi-quantitative
analysis, it is imprecise and generates false negatives with some frequency.
A variant of cPCR called "quantitative real-time PCR" (qPCR) became popular in the 2000s. It
uses a quantitative approach that allows real-time monitoring of the amplification of the target
PCR fragment using fluorophores that bind to double stranded DNA or linked to probes. The
most commonly used method is SYBR Green: fluorophore binds to double stranded DNA
molecules produced during amplification of the target fragment, leading to the emission of
fluorescence during the PCR. This method has the disadvantage of not being able to directly
discriminate the amplification of nonspecific DNA fragments, which is usually solved by
analyzing the dissociation curve. In contrast, the TaqMan method uses a probe containing
between 13 and 30 nucleotides, specifically for the target sequence and combined with a
fluorophore and a fluorescence inhibitor. During polymerization of the target fragment, DNA
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polymerase degrades the probe and fluorescence is emitted. The use of this technique enables
an increase in the specificity of this method.
Various PCR-based protocols have been developed for the detection of parasite's DNA and
CVL diagnosis. However, the methods used may vary with respect to several parameters, such
as fluorophores, probes, target regions and tissue used for detection of target DNA (Table 2),
making it difficult to do a comparative analysis between the different protocols. It is known
that the sensitivity and specificity of PCR for detection of Leishmania sp. depends on many
factors such as the physico-chemical conditions of the reaction, the concentration and nature
of the sample DNA, the probes, and oligonucleotide primers selected for the target region [44,
127, 128]. The protocols standardization based on changes in previous parameters is the key
step to increased sensitivity, specificity and reproducibility of the tests.
The PCR protocol sensitivity is also affected by the type of tissue used in the detection of
Leishmania sp. DNA. A wide variety of clinical samples can be used such as blood, lymph node,
bone marrow, conjunctiva, skin and spleen. The sensitivity tends to vary, since the parasitic
load is not equally distributed in all tissues [4, 7, 129-133]. However, studies have shown that
PCR can detect the presence of Leishmania DNA in a similar way, even in different tissues as
demonstrated by Manna et al. (2004) in a study using 56 dogs naturally infected with L.
infantum, which evaluated samples from lymph nodes, skin and blood by cPCR obtaining
positivity values of 99%, 95% and 94% respectively [133]. Similarly, Ferreira et al. (2013), using
qPCR, obtained positivity values on the order of 90% for blood samples, 97% for skin biopsy,
98% for conjunctival swab samples and 100% for bone marrow samples [134]. Other studies
showed better results for sensitivity to certain tissue, such as Maya et al. (2009) that evaluated
dogs with different clinical profiles and demonstrated that the use of cPCR for parasite DNA
detection on lymph node aspirate would be ideal for the early CVL diagnosis in symptomatic
animals [132], a finding later corroborated by Lombardo et al. (2012) and Belinchon-Lorenzo
(2013) [135, 136]. However, in the absence of lymphadenopathy, other studies showed that
bone marrow aspirates offered better sensitivity, since it has a higher parasite load in relation
to lymph nodes [132, 137]. Studies indicate bone marrow as the tissue in which PCR has greater
sensitivity; as reported by Andrade et al. (2002), where bone marrow aspirate gave a sensitivity
of 100% [138]. However Ferreira et al (2008) obtained positivity values of only 50% for bone
marrow aspirates from asymptomatic and 77% from symptomatic dogs using cPCR followed
by hybridization, using cloned kDNA-probes from mini circles of L. infantum [139].
The selection of target region in the parasite genome is important because the variation in the
number of copies, depending on the region, influences the sensitivity for detecting the
parasite's DNA and for quantification of parasite load. The highly conserved and repetitive
regions are the most commonly employed, such as the gene for subunit ribosomal RNA (rRNA)
or minicircle kinetoplast DNA (kDNA) [21, 23, 127, 140, 141], that has 40-200 copies per cell,
while the kDNA minicircles have about 10,000 copies distributed among 10 different classes
of sequences. Using this as a target region confers high sensitivity to PCR [142]. For quantifi‐
cation of the parasitic load is recommended to normalize the amount of parasite gene ampli‐
fication in relation to a constitutive gene derived from the host genome in order to correct
distortions caused by errors in the DNA used in the PCR reaction [127].
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Ferreira et al.
2012
Syber
α pol DNA NI Yes Yes ß - canine actin
(80) Infected
dogs
Conjunctival
swab, blood, bone
marrow and skin
Comparative1,2
Skin > Bone
marrow >
Conjunctival
swab > Blood
Solcà et al.
2014#
TaqMan
kDNA
0.01
parasites/
reaction
Yes Yes 18S eukaryoticrRNA (51) Dogs
Bone marrow,
conjunctival swab,
lymph node, skin
and spleen
Comparative1,2
Spleen > Blood
> Lymph node >
Skin > Bone
marrow >
Conjunctival
swab
Belinchón-
Lorenzo et al.
2013
TaqMan
kDNA
0.0079
parasites/
reaction
Yes Yes 18S eukaryoticrRNA (28) Dogs
Blood, hair and
lymph node Comparative
 2 Lymph node >
Hair = Blood
Ferreira et al.
2013
Syber
α pol DNA NI Yes Yes ß - canine actin
(62) CVL
positive dogs
Conjunctival,
nasal and ear
swab, blood, Bone
marrow and skin
Comparative
1,2
Skin = Nasal
swab and bone
marrow >
Conjunctival
swab > Oral
swab > Ear
swab
Geisweid et al.
2013
Syber
kDNA NI Yes No Canine NCX1
(74) CVL
suspected dogs
Conjunctival
swab, blood, bone
marrow and
lymph node
Comparative 2
Bone marrow >
Conjunctival
Swab
Reis et al. 2013 Syberα pol DNA NI Yes No G3PDH
(60)
Seropositive
dogs
Skin and spleen Comparative1,2 Spleen > Skin
Pennisi et al.
2005
NI
kDNA NI No No --- (6) Treated dogs
Blood, lymph
node and skin Not comparative ---
Francino et al.
2006
TaqMan
kDNA
0.001
parasites/
reaction
Yes No 18S eukaryoticrRNA
(15) Dogs with
clinical signs
suggestive of
CVL
Blood and bone
marrow Comparative
1, 2 Bone marrow >
Blood
Rodriguez-
Cortez et al.
2007
TaqMan
kDNA
0.001
parasites/
reaction
Yes Yes 18S eukaryoticrRNA
(6)
Experimentally
infected dogs
Blood, bone
marrow, liver,
lymph node, skin
and spleen
Not comparative ---
Solano-Gallego
et al. 2007
Syber
kDNA
7
parasites/ml Yes No Canine GAPDH
(10)
Symptomatic
Blood, bone
marrow and urine Comparative
 2 Bone marrow >
Blood
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dogs naturally
infected > Urine
Manna et al.
2008
TaqMan
kDNA
0.001
parasites/ml Yes Yes ß - actin
(18) Naturally
infected treated
dogs
Blood, lymph
node and skin Comparative
 2 Lymph node >
Skin > Blood
Manna et al.
2009
TaqMan
kDNA NI Yes Yes ß - actin (56) Dogs
Blood and lymph
node Not comparative ---
Quaresma et
al. 2009
Syber
kDNA
0.1pg
DNA/ml Yes Yes
ß -canine
globin (35) Dogs
Blood and bone
marrow Comparative
2 Blood = Bone
marrow
Maia et al.
2010
TaqMan
kDNA
1 parasite /
reaction Yes No ß - canine actin
(12)
Experimentally
infected dogs
Blood, bone
marrow, buffy
coat, liver, lymph
node, skin and
spleen
Comparative1, 2
Spleen / Buffy
coat / Liver /
Lymph node /
Bone marrow /
Skin > Blood
Galletti et al.
2011
TaqMan
kDNA
0.03
parasite/
reaction
No No --- (88) Dogs
Conjunctival
swab, Lymph
node, bone
marrow and
blood
Comparative1 ---
Lombardo et
al. 2011
TaqMan
kDNA NI No No --- (138) Dogs
Blood,
conjunctival and
oral swabs and
lymph node
Comparative1 ---
Naranjo et al.
2011
TaqMan
kDNA NI Yes No
18S eukaryotic
rRNA (22) Sick dogs
Main lacrimal
gland, tarsal gland
and nictitating
membrane gland
Comparative1 ---
* Study design: Comparative1: aim to compare different diagnostic techniques results; Comparative2: aim to compare
different canine tissue sensitivity; ** Sensitivity: evaluation of Leishmania sp. detection in the different canine tissues; NI:
Not informed; # submitted; a: qPCR inhibition control; b: qPCR normalization control.
Table 2. List of papers using the qPCR technique for Leishmania sp. detection in different canine tissues, comparing
the different methodologies and the use of internal control of the reaction
In a cytological study, Reis et al. (2006) showed that the spleen is a major organ where parasite
density is high throughout the course of CVL in both symptomatic and asymptomatic dogs
[74]. Saldarriaga et al. (2006) demonstrated in a study using dogs submitted to intradermal
experimental infection with promastigotes of Leishmania sp. ninety-six hours after inoculation,
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parasites were found in the lymph nodes and spleen of infected animals [148]. Another study
revealed varying degrees of splenomegaly in most dogs infected with Leishmania sp. [132]. Reis
et al. (2013) found 100% of positivity in spleen samples of 37 infected animals [149]. These
findings make the spleen the best choice for the CVL diagnosis employing molecular techni‐
ques [150]. Nevertheless, obtaining spleen samples, even if tolerated by the animal, can incur
a risk of hemorrhage and internal lesions [150]. However, in a study performed by Barrouin-
Melo et al. (2006) in which 257 splenic punctures were performed, only two animals had the
intestinal loop aspirated and one animal experienced bleeding at the puncture site [151]. These
risks can be minimized by organ visualization using ultrasound devices, which allow a guided
and safe collection of tissue sample [152]. In a recent study performed by the present authors,
1,200 dogs were punctured with the aid of ultrasound machine without any incident (unpub‐
lished data).
Splenic collection, bone marrow and lymph node aspirates are considered invasive procedures
[153] in addition to having an elevated cost compared to blood collection. Thus, it can be
recommended to use samples obtained less invasively, such as blood and conjunctival swabs
[136, 154, 155]. These samples are quick and easy to obtain, and it is low-cost compared to more
invasive procedures, in addition to their higher acceptance by animal owners [132, 154, 155].
Some studies have shown that detection of parasites in the peripheral blood is less sensitive
compared to other tissue samples such as spleen, bone marrow, lymph nodes and skin and
tends to have variable parasitic load in accordance with the stage of infection [129, 141, 156].
However, depending on the technique and the target, blood can be used for detection of
Leishmania sp. infection even when there is a low parasitic load [142, 157]. Maia et al. (2009)
showed that the use of peripheral blood samples, extracted from soaked filter paper, from 29
infected dogs showed 93.1% positivity in cPCR of kDNA, suggesting that this tissue can be
used as a complement for serological diagnosis [132]. However, despite blood has the advant‐
age of being less invasive than spleen, bone marrow and lymph node punctures, this tissue
contains hemoglobin that may acts as inhibitor to the PCR reaction, which are usually
neutralized by the addition of albumin, and also present a high variability in parasite detection,
due to the fluctuation of parasitemia according to the stage of infection.
According to Solano-Gallego et al. (2001) in comparison to other tissues, skin has the greatest
sensitivity [4]. In a study involving 80 naturally infected dogs, Ferreira et al. (2012) showed
that skin is the tissue with the higher parasitic load, showing no significant difference between
symptomatic and asymptomatic animals [139]. Reis et al (2013) used skin samples from 37
animals and by means of qPCR obtained a sensitivity of 97.3% in identifying infected dogs.
Nevertheless, other noninvasive samples are being tested for molecular diagnosis of CVL, such
as conjunctival swabs [149]. Using this type of sample with cPCR, Ayali-Strauss et al (2004)
were able to detect 92% of the symptomatic animals evaluated in the study, using spleen or
lymph node aspirates, they detected 86%whereas using peripheral blood or white blood cells
they detected, respectively, only 17% and 57% of the infected dogs [158]. Leite et al (2010) also
succeeded in detecting the parasite DNA from conjunctival swabs of asymptomatic animals
by the technique of cPCR followed by kDNA-probe hybridization [159]. Lombardo (2012)
using qPCR technique with conjunctival swabs obtained similar results to those obtained with
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more invasive samples such as lymph node aspirates [136]. Ferreira et al. (2012) used cPCR
followed by kDNA-probe hybridization of blood samples, skin, marrow and conjunctival
swabs. The use of swabs gave the best results for detection of infection in both symptomatic
and asymptomatic dogs, showing to be a suitable sample for the molecular diagnosis of CVL.
Furthermore, Di Muccio et al (2012) argue that the use of nested PCR from conjunctival swabs
shown to be the least invasive procedure with the best performance for the diagnosis of CVL
in asymptomatic animals [156].
Among other less invasive sample types investigated, Solano-Gallego et al (2007) evaluated
urine samples with qPCR technique, but the results described showed positivity only in dogs
with severe renal injury [160]. Naranjo et al. (2012) identified the presence of Leishmania sp.
DNA in lacrimal glands of infected dogs using qPCR, with positive correlation between
positivity and the presence of ocular lesions [161]. Recently, Belinchon-Lorenzo (2013), using
qPCR, demonstrated the presence of Leishmania kDNA in the hair and keratinocytes of infected
animals. According to the authors, the use of the non-invasive hair sample for the diagnosis
of CVL would be advantageous because it is easy to collect, handle, transport, and store [135].
However, further studies should be conducted to determine the sensitivity of this method.
Laboratory – Country
Tests Price
Serology cPCR qPCR qPCR andCitology
Elleviti – Torino, Italy 26.80* --- 63.00* ---
Scanelis - Toulouse, France --- --- 60.30* ---
Laboratoire d'Anatomie Pathologique Vétérinaire du Sud-Ouest –
Toulouse, France --- --- --- 127.30*
Laboratório Veterinário INNO – Braga, Portugal 20.60* 54.40* --- ---
Instituto Nacional de Investigação Agrária e Veterinária, I.P. –
Lisbõa, Portugal 28.00* 41.20* --- ---
Centro de Investigación y Análisis Biológicos – Madrid, Spain 13.60* 60.30* 73.70* ---
Texas Veterinary Medical Diagnostic Laboratory – San Antonio TX,
USA 19.20 --- --- ---
Cornell University - Ithaca NY, USA 22.50 60.00 --- ---
Hermes Pardini - Belo Horizonte MG, Brazil 17.20* 60.20* --- ---
Análisis Biológicos– Chapecó SC, Brazil 9.40* 42.15* 72.25* --
Laborlife - Rio de Janeiro RJ, Brazil 30.10* 77.40* --- ---
*Prices in Euros (€) and Brazilian Real (R$) converted in US dollars (U$), quotation of November 14th of 2013. €1 = aprox.
U$ 1.34 - €1 = aprox.R$ 0.43
Table 3. Cost of the main diagnostic test for CVL in different laboratories consulted in the second semester of 2013 in
U$
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Despite the high sensitivity and specificity, the use of molecular methods for the CVL diagnosis
presents some limitations to its use in epidemiological surveys: i) it has higher costs than other
techniques (Table 3) used in the CVL diagnosis, including reagent and equipment costs; ii) it
presents relative complexity in its implementation, requiring personnel with training in the
execution of PCR reactions. However, this method has advantages in terms of sensitivity and
specificity when compared to other diagnostic techniques, which justify its use in confirming
cases screened by serology [24, 132]. Particularly due to the possibility of quantifying target
DNA, qPCR may be used to monitor the parasitic load of the animal during the experimental
infection, or during and after treatment in countries where it is permitted [35-37, 162].
Compared with cPCR, qPCR enables a reduction in the probability of false positives resulting
from amplification artifacts and greater speed in obtaining results, once electrophoresis is no
longer performed [163].
4. Conclusion
In summary, detailed clinical evaluation complemented with highly sensitive test allows
proper identification of infected dogs in an endemic area. Evidence shows that the use of a
rapid serological test associated with a molecular diagnostic test with high specificity, such as
qPCR, is required for identification of all infected dogs, both asymptomatic and symptomatic.
On the other hand, for sick dogs a correct diagnosis is necessary either to perform dog culling
in countries where this measure is used as a control strategy of VL or to define treatment. In
this case, a detailed clinical evaluation should be associated with biochemistry and hemato‐
logical tests to identify signs of renal and hepatic failure, in conjunction with a serological test
to confirm animal clinical condition.
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